AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Rebzopar-DSR Capsule

Prescription Icon
Prescription Required

Marketer

Aqmax Biotech Pvt.Ltd

Salt Composition

Domperidone (30mg) + Rabeprazole (20mg)

Overview Rebzopar-DSR Capsule

Gastro-esophageal reflux disease (GERD), or acid reflux, can be managed with Rebzopar-DSR Capsules, a combination medication. This treatment alleviates symptoms like heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion for improved comfort. Dosage and duration should strictly follow your physician's instructions; the prescribed regimen depends on individual response and condition severity. Consistent use, as directed, is crucial; premature discontinuation may lead to symptom recurrence and condition exacerbation. Always inform your healthcare provider of all other medications you are using, as interactions are possible. Common, usually transient, side effects include diarrhea, abdominal pain, dry mouth, headache, flatulence, and fatigue. Report any concerning side effects immediately. Dizziness and drowsiness are potential side effects; refrain from driving or activities requiring alertness until the medication's impact is understood. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle adjustments, such as consuming cold milk and avoiding hot beverages, spicy foods, and chocolate, can enhance treatment efficacy. Prior to commencing treatment, disclose any kidney or liver conditions, pregnancy, pregnancy planning, or breastfeeding to your doctor.

Uses of Rebzopar-DSR Capsule

Managing gastroesophageal reflux and peptic ulcers.

Major Benefits of Rebzopar-DSR Capsule:

Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the Rebzopar-DSR Capsule whole; avoid chewing, crushing, or fracturing it. Consume it on an empty stomach.

Common Side effects of Rebzopar-DSR Capsule:

  • Cough
  • Headache
  • Diarrhea
  • Dizziness
  • Inflammation of the nose
  • Abdominal pain
  • Vomiting
  • Weakness
  • Nasal congestion (stuffy nose)
  • Insomnia (difficulty in sleeping)
  • Fundic gland polyps
  • Nausea
  • Constipation
  • Flatulence
  • Back pain
  • Pharyngitis

How to use Rebzopar-DSR Capsule:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Rebzopar-DSR Capsule whole; avoid chewing, crushing, or fracturing it. Administer the capsule on an empty stomach.

How Rebzopar-DSR Capsule works:

Rebzopar-DSR Capsules contain Domperidone and Rabeprazole, two active ingredients working in synergy. Domperidone, a gastrointestinal motility stimulant, enhances the transit of food through the upper digestive system. Rabeprazole, a proton pump inhibitor (PPI), decreases stomach acid production, thereby alleviating acid reflux symptoms such as heartburn and indigestion.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when using Rebzopar-DSR Capsules with alcohol. Seek medical advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

Employing Rebzopar-DSR Capsule during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescription. Physician consultation is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Rebzopar-DSR capsules while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Rebzopar-DSR Capsules might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Exercise caution when administering Rebzopar-DSR Capsules to individuals with renal impairment. Dosage modification for Rebzopar-DSR Capsules might be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Rebzopar-DSR Capsules cautiously, potentially requiring dosage modification. Consult your physician. Rebzopar-DSR Capsules are contraindicated for individuals with moderate to severe hepatic dysfunction.

What if you forget to take Rebzopar-DSR Capsule :

Should you forget a Rebzopar-DSR Capsule dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Rebzopar-DSR Capsule

LabelValue
Addictive None.
Medication Classification Gastrointestinal system

FAQs on Rebzopar-DSR Capsule

Rebzopar-DSR Capsules contain Domperidone and Rabeprazole, working together to manage heartburn, acid reflux (GERD), and ulcers affecting the stomach or duodenum. GERD involves stomach acid backing up into the esophagus. Domperidone aids in reducing vomiting by stimulating gut motility, facilitating smoother food passage through the stomach.
Patients exhibiting hypersensitivity to rabeprazole, domperidone, or any excipient in Rebzopar-DSR Capsules should avoid its use. Individuals with pre-existing hepatic or renal impairment require careful monitoring when considering this medication.
Indeed, Rebzopar-DSR Capsules may induce xerostomia. This side effect is attributed to the Domperidone component. To alleviate dry mouth, increase your fluid intake. Keep a water source readily available overnight. Reduce alcohol consumption and abstain from smoking. For dry mouth, utilize alcohol-free mouthwash to minimize the potential for dental caries.
Diarrhea is a potential side effect of Rebzopar-DSR Capsule. If diarrhea occurs, increase your fluid intake. Restrict consumption of greasy or deep-fried foods while taking this medication. Consult your physician if diarrhea continues or if you observe dehydration symptoms such as reduced urination and dark, concentrated urine.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines printed on the packaging or label. Discard any remaining medication. Prevent accidental ingestion by children, pets, and others.
Rebzopar-DSR Capsules are generally well-tolerated. Nevertheless, some individuals may experience typical side effects such as diarrhea, abdominal discomfort, gas, dry mouth, vertigo, or headache. Less frequent or infrequent adverse reactions are also possible. Report any ongoing issue to your physician during treatment.
Optimal absorption of Rebzopar-DSR Capsule is achieved when administered prior to the first meal or while fasting.
Taking Rebzopar-DSR Capsules may raise the likelihood of an abnormal heart rhythm (severe arrhythmias). While this is a significant adverse reaction, the probability of occurrence is quite small. However, the risk might be marginally elevated for individuals over 60.
Rebzopar-DSR Capsules contain domperidone and rabeprazole, working together to manage acidity, heartburn, and gastroesophageal reflux disease (GERD). This medication addresses GERD, a condition characterized by stomach acid reflux into the esophagus, and also treats gastric and duodenal ulcers. The domperidone component facilitates improved gut motility, thereby reducing vomiting and promoting efficient food passage through the stomach.
Individuals exhibiting hypersensitivity to rabeprazole, domperidone, or any other excipients within Rebzopar-DSR Capsules should avoid its use. Patients with pre-existing hepatic or renal impairment require careful monitoring while taking this medication.
Indeed, Rebzopar-DSR Capsules may induce xerostomia (dry mouth), a side effect attributed to their Domperidone component. To alleviate this, increase your fluid intake; keeping water readily available, especially overnight, is recommended. Reducing alcohol consumption and abstaining from smoking are also advisable. For dry mouth sufferers, alcohol-free mouthwash is preferable to mitigate the potential for dental caries.
Diarrhea is a potential side effect of Rebzopar-DSR Capsule. If diarrhea occurs, increase your fluid intake. Refrain from consuming high-fat foods while taking this medication. Consult your physician if diarrhea continues or if you observe dehydration symptoms such as reduced urination and dark, concentrated urine.
Rebzopar-DSR Capsules are generally well-tolerated. Nevertheless, some individuals may experience common adverse reactions including diarrhea, abdominal pain, gas, dry mouth, vertigo, and headache. Less frequent or rare side effects are also possible. Report any ongoing issues to your physician during treatment.
Optimal absorption of Rebzopar-DSR Capsule is achieved by taking it before breakfast or on an empty stomach.
Taking Rebzopar-DSR Capsules may raise the likelihood of experiencing an abnormal heart rhythm, a potentially severe complication. While this adverse effect is serious, its occurrence is infrequent. Individuals over 60 may face a marginally elevated risk.
Store this medication in its original, tightly sealed container or packaging. Follow the storage instructions provided on the label or packaging. Discard any leftover medication. Prevent access by children, pets, and others.
Rebzopar-DSR Capsule
70
MRP 85
17% off